S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

GH Guardant Health Inc

30.44

-0.93 (-2.96%)

28 Dec 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The shares sold in this filing were acquired and paid for between 03/15/2024 and 11/15/2024.

Date of Notice

12/13/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

09/11/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Musa Tariq

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Guardant Health Charts.

Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Guardant Health Charts.

Guardant Health Inc News

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
Saturday 21 December 2024 (1 week ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (1 week ago) • Edgar (US Regulatory)

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
Thursday 19 December 2024 (1 week ago) • Business Wire

Form 144 - Report of proposed sale of securities
Thursday 19 December 2024 (1 week ago) • Edgar (US Regulatory)

Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
Thursday 19 December 2024 (1 week ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 14 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium
Tuesday 10 December 2024 (3 weeks ago) • Business Wire

More Guardant Health Inc News Articles

WisdomTree BTP 10Y 3x Da...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions